Covalent organic framework (cof): a drug and carrier to attenuate retinal ganglion cells death in an acute glaucoma mouse model

HIGHLIGHTS

• who: Ke Yao and colleagues from the Department of Ophthalmology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China have published the Article: Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model, in the Journal: Polymers 2022, 14, 3265. of 10/08/2022
• what: The authors aim to investigate the use of organic framework (COF) nanopArticles in the local treatment of glaucoma both as a means of protecting retinal ganglion cells (RGCs) and as a carrier for delayed release . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.